Mycosynthetix owns a unique collection of fungi that are the source of a rich variety of fungal metabolites for lead discovery for medicine and agriculture.

Archive | Press Releases

RSS feed for this section

Green Ethanol from Biomass? Verenium Looks to Mycosynthetix Fungi

“Fungi are the most prolific degraders of plant biomass in nature and are expected to hold the keys to unlocking the potential of cellulose as a renewable feedstock.” Shortly after the posting of this release, Verenium’s biofuels division was acquired by British Petroleum. Mycosynthetix’ contract has been transferred to BP in the exchange.

Read full story

Mycosynthetix Awarded an SBIR Grant to Work on New Tuberculosis Antibiotics

Mycosynthetix, Inc. was recently awarded a Phase I Small Business Innovation Research grant from the National Institutes of Allergy and Infectious Diseases for the project New Tuberculosis Antibiotics from Filamentous Fungi.

Read full story